Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 975

BillFederalSenateIn Committee
Project BioShield II Act of 2005
About This Bill
Committee
Latest Action · July 21, 2005
Committee on Health, Education, Labor, and Pensions. Held a roundtable discussion of the bill.
Congress
109th (2005–2007)
Introduced
April 28, 2005
Cosponsors (2)
0D 2R
View PDF ↗

Summary

Highlight any text to annotate
Project BioShield II Act of 2005 - Establishes: (1) the Terrorism and Infectious Disease Countermeasure Purchase Fund; (2) procurement pools for qualified countermeasures and security countermeasures; (3) the International Public Health Advisory Committee to develop strategies for establishing such pools; (4) the Office of Public Health Countermeasure Development within the Department of Health and Human Services (HHS) ; (5) the Office of Medical Readiness within the Office of the Secretary of the Department of Homeland Security (DHS) to assume functions of the National Disaster Medical System and the Metropolitan Medical Response System; (6) the National Emergency Medical Readiness and Response Board within DHS to oversee emergency medical response plans; (7) the National Center for Healthcare Technology Development to manage NIH intellectual property; (8) the Millennium Medicine Discovery Award; (9) the Office of the Deputy Commissioner for Biological, Chemical, Nuclear, Radiological and Infectious Disease Products; and (10) the Global Disease Detection Trust Fund. Creates incentives for the development of countermeasures, including: (1) payments to manufacturers; (2) accelerated approval of countermeasures; (3) patent term restoration and extension; (4) exclusive marketing; (5) federal tax incentives; (6) reimbursements for production costs; (7) expedited processing of visa applications; (8) grants and contracts for the construction and management of biosafety level 3-4 facilities; and (9) grants and scholarships for personnel to conduct biodefense and infectious disease research. Sets forth provisions regarding necessary research for countermeasure development, including research regarding: (1) diagnostics; (2) detection technology; (3) infectious diseases; (4) accurate animal models; (5) biologics; (6) vaccine adjuvants; (7) the production of cell culture; (8) vaccines; (9) zoonotic disease surveillance; and (10) agroterrorism research. Bioshield Export Priority Act - Requires the Secretary of Commerce or the Secretary of Health and Human Services to expedite the processing of requests to export restricted items necessary to procure countermeasures.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.